2nd Quarter - Report

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Firm
Client
Income
—
Expenses
$2,110,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

15 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Trade Promotion Authority S.1900/H.R. 3830: Bipartisan Congressional Trade Priorities Act of 2014Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Drug Importation H.R. 4660: Commerce, Justice, Science and Related Agencies Appropriations Act for FY 2015 Intellectual Property International Enforcement Compulsory Licensing India Issues Foreign Agricultural Biotechnology Laws and Regulations China Biotechnology Regulations Asynchrony of International Approvals TransPacific Partnership Regulatory Transparency Data and Intellectual Property Protections for Pharmaceuticals Sanitary and Phytosantiary Issues International Trade Commission Reform Transatlantic Trade and Investment Partnership Intellectual Property Issues Ag-Biotech Issues Regulatory Harmonization/Transparency Biosimilars Colombia Biologics Regulations Clinical Trial Data Sharing and Disclosure EU Policies

Contacted: Patent & Trademark Office (PTO); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Securities & Exchange Commission (SEC); Natl Economic Council (NEC); Medicare Payment Advisory Commission (MedPAC); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Environmental Protection Agency (EPA); Natl Security Council (NSC); Health Resources & Services Administration (HRSA); U.S. Trade Representative (USTR)

Bills named: H.R. 3830 (113th), S. 1900 (113th), H.R. 4660 (113th)

Budget/Appropriations BUD

Funding for FDA Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015Funding for USDA Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 Funding for Biomass Crop Assistance Program Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Sequestration of PDUFA Fees HR 2725: Food and Drug Administration Safety over Sequestration Act of 2013 S. 1413: FDA User Fee Protection Act Agriculture, Rural Development, FDA and Related Agencies Appropriations Act for FY 2015 Energy Basic Research Funding Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Funding for Renewable Chemicals/Bio-based Products Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products Funding for Biofuels Department of Defense Funding of Advanced Biofuels Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Department of Defense Appropriations Act for FY 2015 Department of Interior, Environment, and Related Agencies Appropriations for FY 2015 Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Funding for Biorefineries Department of Defense Funding of Advanced Biofuels Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Energy and Water Development and Related Agencies Appropriations Act for FY 2015

Contacted: Securities & Exchange Commission (SEC); Centers For Medicare and Medicaid Services (CMS); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Environmental Protection Agency (EPA); Medicare Payment Advisory Commission (MedPAC); Agriculture, Dept of (USDA); SENATE; Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Natl Security Council (NSC); Office of Management & Budget (OMB)

Bills named: S. 1413 (113th), H.R. 2725 (113th)

Consumer Issues/Safety/Products CSP

Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015Genetically Engineered (GE) Animals Labeling GE Animal Models of Human Disease FDA Approval Agriculture, Rural Development, FDA and Related Agencies Appropriations Act for FY 2015 Amendment on GE Salmon Labeling Amendment to Restrict FDA Approval of GE Salmon Drug Importation H.R. 4660: Commerce, Justice, Science and Related Agencies Appropriations Act for FY 2015 Review and Labeling of Food Derived From Biotechnology Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 H.R. 4432: Safe and Accurate Food Labeling Act Funding for FDA Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Drug Evaluation and Review Implementation of the FDA Safety and Innovation Act 21st Century Cures Initiative Compassionate Use/Expanded Access FDA Proposed Rule on Changes to Drug Labeling Special Medical Use/Limited Population Drugs H.R. 4475: Compassionate Freedom of Choice Act H.R. 2090: The Patient Choice Act H.R. 3742: Antibiotic Development to Advance Patient Treatment Act of 2013 Biosimilars Colombia Biologics Regulations Naming Implementation of Affordable Care Act Interchangeability and Pharmacy Substitution USDA/APHIS Agricultural Biotechnology Regulations Coexistence of Production Systems Efficient Science-Based Review of Biotech Products Agriculture, Rural Development, FDA and Related Agencies Appropriations Act for FY 2015 Drug Manufacturing, Quality & Distribution Implementation of H.R. 3204: The Drug Quality and Security Act Compounding Sunshine Act Implementation

Contacted: Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Health Resources & Services Administration (HRSA); Natl Security Council (NSC); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Medicare Payment Advisory Commission (MedPAC); SENATE; Securities & Exchange Commission (SEC); Natl Economic Council (NEC); Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 4475 (113th), H.R. 3204 (113th), H.R. 3742 (113th), H.R. 4660 (113th), H.R. 2090 (113th), H.R. 4432 (113th)

Fuel/Gas/Oil FUE

Funding for Biomass Crop Assistance Program Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015Biofuels (Non-Funding) Renewable Fuel Standard Production Tax Credit Extension Accelerated Depreciation Extension H.R. 3758: Second Generation Biofuel Extension Act of 2013 Renewable Chemicals/Bio-based Products (Non-Funding) Bonus Depreciation for Renewable Chemical Facilities Implementation of the Agriculture Act of 2014 Expansion of Master Limited Partnerships to Renewable Chemicals New Production Tax Credit for Renewable Chemicals S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act H.R. 2421: Renewable Chemicals Parity Act H.R. 1696/S. 795: Master Limited Partnerships Parity Act Biorefineries (Non-Funding) Implementation of the Agriculture Act of 2014 Energy Basic Research Funding Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Funding for Renewable Chemicals/Bio-based Products Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products Funding for Biofuels Department of Defense Funding of Advanced Biofuels Department of Defense Appropriations Act for FY 2015 Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Department of Interior, Environment, and Related Agencies Appropriations for FY 2015 Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Funding for Biorefineries Department of Defense Funding of Advanced Biofuels Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Toxic Substances Control Act Reform Polloution Prevention Credit for Renewable Chemicals and Bio-based Products

LobbyistCovered position, as disclosed
MATT CARR —
BRENT ALAN DELMONTE —
CHARLES H FRITTS —
TRACEY LATURNER —
ERICK LUTT —
DANA MAURICE O'BRIEN —
RINA SINGH —

Contacted: HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Natl Economic Council (NEC); SENATE; Health Resources & Services Administration (HRSA); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Medicare Payment Advisory Commission (MedPAC); Natl Security Council (NSC); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); Natl Institutes of Health (NIH)

Bills named: H.R. 3084 (113th), S. 795 (113th), H.R. 3758 (113th), S. 1267 (113th), H.R. 1696 (113th), H.R. 2421 (113th)

Homeland Security HOM

Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015

LobbyistCovered position, as disclosed
PHYLLIS ARTHUR —
KELLY CAPPIO —
BRENT ALAN DELMONTE —
TRACEY LATURNER —
SARA RADCLIFFE —

Contacted: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Economic Council (NEC); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Natl Security Council (NSC); SENATE; Environmental Protection Agency (EPA); Securities & Exchange Commission (SEC); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB)

Agriculture AGR

Funding for USDA Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015Review and Labeling of Food Derived From Biotechnology H.R. 4432: Safe and Accurate Food Labeling Act Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 EPA Regulations on Agricultural Biotechnology Efficient Science-Based Review of Biotech Products Department of Interior, Environment, and Related Agencies Appropriations Act for FY 2015 Genetically Engineered (GE) Animals Labeling FDA Approval GE Animal Models of Human Disease Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Amendment to Restrict FDA Approval of GE Salmon Amendment on GE Salmon Labeling Foreign Agricultural Biotechnology Laws and Regulations Asynchrony of International Approvals China Biotechnology Regulations USDA/APHIS Agricultural Biotechnology Regulations Coexistence of Production Systems Efficient Science-Based Review of Biotech Products Agriculture, Rural Development, FDA and Related Agencies Appropriations Act for FY 2015 Transatlantic Trade and Investment Partnership Ag-Biotech Issues TransPacific Partnership Sanitary and Phytosanitary Issues Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Funding for Biomass Crop Assistance Program Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
DAVID EDWARDS —
CATHLEEN ENRIGHT —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —
MATTHEW O'MARA —

Contacted: SENATE; Office of Management & Budget (OMB); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Securities & Exchange Commission (SEC); Centers For Medicare and Medicaid Services (CMS); Natl Economic Council (NEC); Patent & Trademark Office (PTO); Natl Security Council (NSC); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Food & Drug Administration (FDA)

Bills named: H.R. 4432 (113th)

Taxation/Internal Revenue Code TAX

Tax Reform House Ways & Means Committee Discussion Draft (Rep. Camp)Orphan Drug Act Tax Credit Controlled Foreign Corporation Look-Through Rule Extension Renewable Chemicals/Bio-based Products Bonus Depreciation for Renewable Chemical Facilities Expansion of Master Limited Partnerships to Renewable Chemicals New Production Tax Credit for Renewable Chemicals S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act H.R. 1696/S. 795: Master Limited Partnerships Parity Act Biofuels Production Tax Credit Extension Accelerated Depreciation Extension H.R. 3758: Second Generation Biofuel Extension Act of 2013 Research & Development Tax Credit Reforms Extension Permanency H.R.3757: The Igniting American Research Act H.R. 4438: American Research & Competitiveness Act of 2014 H.R.119: To amend the Internal Revenue Code to make permanent the credit for increasing research activities The Start-up Innovation Credit Act (Senator Coons Discussion Draft) The COMPETE Act (Senator Carper Discussion Draft) Capital Formation Investment Incentives Reform of Capital Gains Rules Reform of Net Operating Loss Rules Reform of Passive Loss Rules H.R. 4855: The PARTNER Act S. 1658: The Start-up Jobs and Innovation Act The COMPETE Act (Senator Carper Discussion Draft) House Ways & Means Committee Discussion Draft (Rep. Camp)

Contacted: Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Natl Security Council (NSC); Agriculture, Dept of (USDA); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); U.S. Trade Representative (USTR); Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); SENATE; Food & Drug Administration (FDA); Natl Economic Council (NEC)

Bills named: H.R. 3757 (113th), H.R. 119 (113th), S. 1658 (113th), H.R. 4855 (113th), H.R. 3758 (113th), H.R. 3084 (113th), S. 795 (113th), H.R. 4438 (113th), H.R. 1696 (113th), S. 1267 (113th)

Copyright/Patent/Trademark CPT

TransPacific Partnership Data and Intellectual Property Protections for PharmaceuticalsPatent Reform H.R. 3309: Innovation Act of 2013 S. 1013: Patent Abuse Reduction Act of 2013 S. 1720: Patent Transparency and Improvements Act of 2013 S. 866: Patent Quality Improvement Act of 2013 Targeting Rogue and Opaque Letters (TROL) Act of 2014 (Discussion Draft) FTC Regulation of Patent Demand Letters (Senate Commerce Committee Discussion Draft) Drug Repurposing H.R. 4287/S.2150: Independent Innovator and Repurposing Act Intellectual Property International Enforcement Compulsory Licensing India Issues Transatlantic Trade and Investment Partnership Intellectual Property Issues Patenting of Biological Inventions DNA Patenting and Licensing International Trade Commission Reform

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Health Resources & Services Administration (HRSA); SENATE; Environmental Protection Agency (EPA); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Natl Security Council (NSC); Office of Management & Budget (OMB); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Natl Economic Council (NEC); Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 866 (113th), S. 1720 (113th), S. 2150 (113th), H.R. 4287 (113th), S. 1013 (113th), H.R. 3309 (113th)

Health Issues HCR

Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015Biosimilars Colombia Biologics Regulations Naming Implementation of Affordable Care Act Interchangeability and Pharmacy Substitution Funding for Centers for Disease Control and Prevention Vaccine Programs Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 Vaccine Access/Financing Adult Immunization (Senate Discussion Draft) 340B Drug Pricing Program Implementation of Affordable Care Act Program Implementation & Oversight Departments of Labor, HHS, Education and Related Agencies Appropriations Act for FY 2015 Drug Importation H.R. 4660: Commerce, Justice, Science and Related Agencies Appropriations Act for FY 2015 Funding for FDA Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Independent Payment Advisory Board Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Medicaid Pricing and Rebates Implementation of Affordable Care Act H.R. 1416: The Cancer Patient Protection Act of 2013 National Center for Advancing Translational Science (NCATS) (Non-Funding) Program Implementation Sequestration of PDUFA Fees Agriculture, Rural Development, FDA and Related Agencies Appropriations Act for FY 2015 HR 2725: Food and Drug Administration Safety Over Sequestration Act of 2013 S. 1413: FDA User Fee Protection Act TransPacific Partnership Regulatory Transparency Data and Intellectual Property Protections for Pharmaceuticals Transatlantic Trade & Investment Partnership Regulatory Harmonization/TransparencyDrug Evaluation and Review Implementation of the FDA Safety and Innovation Act 21st Century Cures Initiative Compassionate Use/Expanded Access FDA Proposed Rule on Changes to Drug Labeling Special Medical Use/Limited Population Drugs H.R. 4475: Compassionate Freedom of Choice Act H.R. 2090: The Patient Choice Act H.R. 3742: Antibiotic Development to Advance Patient Treatment Act of 2013 Orphan Drug Act Tax Credit Clinical Trial Data Sharing and Disclosure EU Policies Drug Manufacturing, Quality & Distribution Implementation of H.R. 3204: The Drug Quality and Security Act Compounding Sunshine Act Implementation Medicare Physician Payment Sustainable Growth Rate Formula S. 2110: Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014 Drug Repurposing H.R. 4287/S.2150: Independent Innovator and Repurposing Act

Contacted: Securities & Exchange Commission (SEC); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Health Resources & Services Administration (HRSA); Natl Security Council (NSC); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; Patent & Trademark Office (PTO); Natl Economic Council (NEC); Office of Management & Budget (OMB); Natl Institutes of Health (NIH)

Bills named: S. 2110 (113th), H.R. 2725 (113th), S. 2150 (113th), H.R. 2090 (113th), H.R. 1416 (113th), H.R. 4660 (113th), H.R. 3204 (113th), S. 1413 (113th), H.R. 4287 (113th), H.R. 4475 (113th), H.R. 3742 (113th)

Small Business SMB

Sarbanes Oxley Section 404 (b) Mandatory Audit Firm Rotation H.R. 1564/S. 1526: The Audit Integrity and Job Protection ActCapital Formation Investment Incentives Reform of Capital Gains Rules Reform of Net Operating Loss Rules Reform of Passive Loss Rules H.R. 4855: The PARTNER Act S. 1658: The Start-up Jobs and Innovation Act The COMPETE Act (Senator Carper Discussion Draft) House Ways & Means Committee Discussion Draft (Rep. Camp) Reform of SEC Regulation D Implementation of Jumpstart Our Business Start-ups (JOBS) Act H.R. 4554: Restricted Securities Relief Act H.R. 4570: Private Placement Improvement Act Expansion of Exemption under SEC Regulation A H.R. 4565: Start-up Capital Modernization Act Legislative Amendments to SEC Rule 12b-2 Filing Status Definitions H.R. 2629: The Fostering Innovation Act Small Business Innovation Research (SBIR) Program XBRL Exemption for Small Public Companies H.R. 4164: Small Company Disclosure Simplification Act Stock Exchange Tick Size H.R. 3448: The Small Cap Liquidity Reform Act H.R. 1952: The Spread Pricing Liquidity Act Capital Market Enhancements H.R. 4568: Small Business Freedom to Grow Act H.R. 4571: To direct the SEC to revise its rules so as to increase the threshold amount for requiring issuers to provide certain disclosures relating to compensatory benefits plans H.R. 3623: Improving Access to Capital for Emerging Growth Companies Act H.R. 4569: Disclosure Modernization and Simplification Act H.R. 4697: To require the SEC to revise the definition of a WKSI to reduce the worldwide market value threshold under the definition

LobbyistCovered position, as disclosed
CHARLES CRAIN —
BRENT ALAN DELMONTE —
ELIZABETH CARTIER ESHAM —
CHARLES H FRITTS —
SHELLY MUI-LIPNIK —

Contacted: Natl Economic Council (NEC); SENATE; Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Natl Institutes of Health (NIH); Natl Security Council (NSC); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4164 (113th), S. 1658 (113th), H.R. 2629 (113th), S. 1526 (113th), H.R. 3448 (113th), H.R. 4568 (113th), H.R. 4855 (113th), H.R. 4570 (113th), H.R. 4565 (113th), H.R. 3623 (113th), H.R. 4569 (113th), H.R. 4554 (113th), H.R. 1952 (113th), H.R. 4697 (113th), H.R. 4571 (113th), H.R. 1564 (113th)

Medicare/Medicaid MMM

Medicare Physician Payment Sustainable Growth Rate Formula S. 2110: Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014Independent Payment Advisory Board Reimbursement for Innovative Products Medicare Part B Physician-Administered Products Medicare Part D Prescription Drug Program Medicaid Pricing and Rebates Implementation of Affordable Care Act H.R. 1416: The Cancer Patient Protection Act of 2013

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Agriculture, Dept of (USDA); Environmental Protection Agency (EPA); Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); Medicare Payment Advisory Commission (MedPAC); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Health & Human Services, Dept of (HHS); Natl Security Council (NSC); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Health Resources & Services Administration (HRSA); Securities & Exchange Commission (SEC)

Bills named: S. 2110 (113th), H.R. 1416 (113th)

Energy/Nuclear ENG

Funding for Biomass Crop Assistance Program Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015Biofuels (Non-Funding) Renewable Fuel Standard Production Tax Credit Extension Accelerated Depreciation Extension H.R. 3758: Second Generation Biofuel Extension Act of 2013 Renewable Chemicals/Bio-based Products (Non-Funding) Bonus Depreciation for Renewable Chemical Facilities Implementation of the Agriculture Act of 2014 Expansion of Master Limited Partnerships to Renewable Chemicals New Production Tax Credit for Renewable Chemicals S. 1267/H.R. 3084: Renewable Chemical Production Tax Credit Act H.R. 2421: Renewable Chemicals Parity Act H.R. 1696/S. 795: Master Limited Partnerships Parity Act Biorefineries (Non-Funding) Implementation of the Agriculture Act of 2014 Energy Basic Research Funding Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Funding for Renewable Chemicals/Bio-based Products Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Expansion of Biorefinery Assistance Program to Renewable Chemicals and Bio-based Products Funding for Biofuels Department of Defense Funding of Advanced Biofuels Department of Defense Appropriations Act for FY 2015 Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Department of Interior, Environment, and Related Agencies Appropriations for FY 2015 Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Funding for Biorefineries Department of Defense Funding of Advanced Biofuels Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Energy and Water Development and Related Agencies Appropriations Act for FY 2015 Toxic Substances Control Act Reform Polloution Prevention Credit for Renewable Chemicals and Bio-based Products

LobbyistCovered position, as disclosed
MATT CARR —
BRENT ALAN DELMONTE —
CHARLES H FRITTS —
TRACEY LATURNER —
ERICK LUTT —
DANA MAURICE O'BRIEN —
RINA SINGH —

Contacted: Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Natl Economic Council (NEC); Food & Drug Administration (FDA); Medicare Payment Advisory Commission (MedPAC); Securities & Exchange Commission (SEC); Natl Institutes of Health (NIH); SENATE; Natl Security Council (NSC); Environmental Protection Agency (EPA); Office of Management & Budget (OMB)

Bills named: H.R. 3084 (113th), S. 1267 (113th), H.R. 2421 (113th), H.R. 1696 (113th), S. 795 (113th), H.R. 3758 (113th)

Food Industry (safety, labeling, etc.) FOO

Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015Genetically Engineered (GE) Animals Labeling GE Animal Models of Human Disease FDA Approval Agriculture, Rural Development, FDA and Related Agencies Appropriations Act for FY 2015 Amendment on GE Salmon Labeling Amendment to Restrict FDA Approval of GE Salmon Review and Labeling of Food Derived From Biotechnology Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 H.R. 4432: Safe and Accurate Food Labeling Act

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
DAVID EDWARDS —
CATHLEEN ENRIGHT —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —
MATTHEW O'MARA —

Contacted: Patent & Trademark Office (PTO); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); Securities & Exchange Commission (SEC); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Natl Security Council (NSC); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Natl Economic Council (NEC); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR)

Bills named: H.R. 4432 (113th)

Animals ANI

Livestock Cloning/Product Labeling Discussions with EU on Animal Cloning Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015Genetically Engineered (GE) Animal Labeling FDA Approval GE Animal Models of Human Disease Agriculture, Rural Development, FDA, and Related Agencies Appropriations Act for FY 2015 Amendment to Restrict FDA Approval of GE Salmon Amendment on GE Salmon Labeling

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
DAVID EDWARDS —
CATHLEEN ENRIGHT —
TRACEY LATURNER —
DANA MAURICE O'BRIEN —

Contacted: U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); SENATE; Medicare Payment Advisory Commission (MedPAC); Agriculture, Dept of (USDA); Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Natl Security Council (NSC); Health & Human Services, Dept of (HHS)

Medical/Disease Research/Clinical Labs MED

Funding for National Institutes of Health Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015Funding for Biodefense/Biomedical/Emergency Preparedness Research, Development and Procurement Departments of Labor, HHS, Education, and Related Agencies Appropriations Act for FY 2015 National Center for Advancing Translational Science (NCATS) (Non-Funding) Program Implementation

Contacted: Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Environmental Protection Agency (EPA); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Natl Institutes of Health (NIH); SENATE; Natl Economic Council (NEC); Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.